Skip to main content
Signal8

Kallebo Lisa Michelle

SEC insider (Form 3/4/5 filer). CIK 0002000724. Chief Accounting Officer at ADC Therapeutics SA (ADCT). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 13, 2026. Located in NEW PROVIDENCE, NJ.

Companies Kallebo Lisa Michelle has filed insider reports for

  • ADC Therapeutics SA (ADCT): Officer, Chief Accounting Officer
Kallebo Lisa Michelle profile photo

Kallebo Lisa Michelle

CIK: 0002000724

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADC Therapeutics SA logo
ADCT

ADC Therapeutics SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Feb 13, 2026
    Award
    Direct
    62.9K shares at avg. $3.99$251K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Feb 13, 2026
    Tax Payment
    Direct
    5.4K shares at avg. $3.99$22K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Dec 6, 2025
    Tax Payment
    Direct
    7.1K shares at avg. $3.29$23K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Feb 13, 2025
    Award
    Direct
    41.9K shares at avg. $1.61$67K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Dec 6, 2024
    Tax Payment
    Direct
    6.5K shares at avg. $3.13$20K

1-5 of 5